Yamamoto R, Wada A, Asada Y, Yuhi T, Yanagita T, Niina H, Sumiyoshi A
Department of Pharmacology, Miyazaki Medical College, Japan.
Naunyn Schmiedebergs Arch Pharmacol. 1994 Apr;349(4):362-6. doi: 10.1007/BF00170881.
As previously reported, N omega-nitro-L-arginine (L-NNA), an inhibitor of nitric oxide (NO) synthesis, decreased transmural field stimulation (TFS)-induced noradrenaline overflow from the isolated perfused rat mesenteric vasculature attached to the intestine. The decrease was attenuated by L-arginine. This suggests that NO may increase noradrenaline release (Yamamoto et al. 1993). The present experiments with this preparation were done in order to monitor changes in vascular perfusion pressure caused by TFS or by noradrenaline infusion in parallel with those in the noradrenaline outflow caused by TFS in the presence of atropine (0.1 mumol/l) (to block acetylcholine-induced release of endothelial NO) and of indomethacin (3 mumol/l) (to inhibit L-NNA-induced production of vasoconstrictor prostanoids). (1) TFS (2-10 Hz) caused a frequency-dependent increase in noradrenaline overflow and perfusion pressure. (2) L-NNA (10 and 30 mumol/l) caused a concentration-dependent inhibition of TFS-induced noradrenaline overflow, whereas the TFS-induced pressure increase was augmented by L-NNA in a concentration-dependent manner. At any given concentration of L-NNA, the potentiation of vasoconstriction by L-NNA became greater in magnitude as the frequency of the TFS was raised. (3) Infusion of noradrenaline (0.38-6 nmol) caused a dose-dependent increase in perfusion pressure up to a value comparable with that caused by TFS. The pressure increase in response to noradrenaline infusion was also enhanced by L-NNA, relatively, to a greater extent than the enhancement, by L-NNA, of the pressure response to TFS.(ABSTRACT TRUNCATED AT 250 WORDS)
如先前报道,一氧化氮(NO)合成抑制剂Nω-硝基-L-精氨酸(L-NNA)可降低经壁场刺激(TFS)诱导的、来自与肠相连的离体灌注大鼠肠系膜血管床的去甲肾上腺素溢出。L-精氨酸可减弱这种降低作用。这表明NO可能增加去甲肾上腺素释放(Yamamoto等人,1993年)。本实验采用该制备方法,目的是在存在阿托品(0.1μmol/L)(以阻断乙酰胆碱诱导的内皮NO释放)和吲哚美辛(3μmol/L)(以抑制L-NNA诱导的血管收缩性前列腺素生成)的情况下,监测由TFS或去甲肾上腺素输注引起的血管灌注压变化,并与TFS引起的去甲肾上腺素流出变化并行监测。(1)TFS(2 - 10Hz)引起去甲肾上腺素溢出和灌注压呈频率依赖性增加。(2)L-NNA(10和30μmol/L)引起TFS诱导的去甲肾上腺素溢出呈浓度依赖性抑制,而TFS诱导的压力增加则被L-NNA以浓度依赖性方式增强。在任何给定的L-NNA浓度下,随着TFS频率升高,L-NNA对血管收缩的增强作用幅度变得更大。(3)输注去甲肾上腺素(0.38 - 6nmol)导致灌注压呈剂量依赖性增加,直至达到与TFS引起的值相当的值。相对于L-NNA对TFS压力反应的增强作用,L-NNA对去甲肾上腺素输注引起的压力增加也有增强作用,且增强程度更大。(摘要截断于250字)